Literature DB >> 7094787

Toxic megacolon secondary to pseudomembranous colitis.

J B Cone, W Wetzel.   

Abstract

Toxic megacolon has rarely been reported in the course of antibiotic-induced pseudomembranous colitis. We have been able to collect 20 cases from the literature and add one new case. The mortality in the collected series was 33 per cent. The critical factor in improving survival is early recognition of the pseudomembranous colitis. Most patients can be managed medically by removal of the offending antibiotic, bowel rest, vancomycin, and steroids. If toxic megacolon develops in the face of appropriate medical management, an aggressive surgical approach is indicated, as with ulcerative colitis. Subtotal colectomy appears to be the procedure of choice.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094787     DOI: 10.1007/BF02553662

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

Review 1.  Clostridium difficile colitis causing toxic megacolon, severe sepsis and multiple organ dysfunction syndrome.

Authors:  Giles Dobson; Caroline Hickey; John Trinder
Journal:  Intensive Care Med       Date:  2003-05-07       Impact factor: 17.440

2.  Pneumoperitoneum without faecal peritonitis in a patient with pseudomembranous colitis.

Authors:  D Klinger; P Radford; J Callin
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-28

Review 3.  Clostridium difficile infection.

Authors:  Latisha Heinlen; Jimmy D Ballard
Journal:  Am J Med Sci       Date:  2010-09       Impact factor: 2.378

Review 4.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

5.  Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis.

Authors:  Eran Elinav; David Planer; Moshe E Gatt
Journal:  Int J Colorectal Dis       Date:  2003-11-15       Impact factor: 2.571

Review 6.  Severe acute diarrhea.

Authors:  Julia I Gore; Christina Surawicz
Journal:  Gastroenterol Clin North Am       Date:  2003-12       Impact factor: 3.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.